Businesses
Here's a look at documents from U.S. and international businesses
Businesses
Featured Stories
Mayer Brown Advises Administrative Agent and Revolving Credit Lender Group on Foundever Group Recapitalization
CHICAGO, Illinois, Aug. 25 [Category: BizLaw/Legal] -- Mayer Brown, a law firm, issued the following news:
* * *
Mayer Brown Advises Administrative Agent and Revolving Credit Lender Group on Foundever Group Recapitalization
A cross-border Mayer Brown team advised the administrative agent and the revolving credit lender group in connection with a debt restructuring and recapitalization transaction of Foundever Group, a global integrated customer experience, digital operations and analytics services provider.
The transaction included, among other aspects, an extension of Foundever's revolving ... Show Full Article CHICAGO, Illinois, Aug. 25 [Category: BizLaw/Legal] -- Mayer Brown, a law firm, issued the following news: * * * Mayer Brown Advises Administrative Agent and Revolving Credit Lender Group on Foundever Group Recapitalization A cross-border Mayer Brown team advised the administrative agent and the revolving credit lender group in connection with a debt restructuring and recapitalization transaction of Foundever Group, a global integrated customer experience, digital operations and analytics services provider. The transaction included, among other aspects, an extension of Foundever's revolvingcredit facility with the consent of all revolving credit lenders, as well as a new three-year $225 million cross-border accounts receivable purchase program (ARPP) provided by certain revolving credit lenders to replace Foundever's prior factoring arrangement.
The transaction also included an equity capital contribution of $225 million by the equity owners of Foundever in connection with a reduction of Foundever's term loan facility.
The Mayer Brown team was led by New York partners Scott Zemser and Christophe Wassaf.
The ARPP aspects of the transaction were also led by Chicago and London partners Massimo Capretta, Patrick Healy and Charles Thain.
* * *
Original text here: https://www.mayerbrown.com/en/news/2026/08/mayer-brown-advises-administrative-agent-and-revolving-credit-lender-group-on-foundever-group-recapitalization
* * *
Mayer Brown Advises Administrative Agent and Revolving Credit Lender Group on Foundever Group Recapitalization
A cross-border Mayer Brown team advised the administrative agent and the revolving credit lender group in connection with a debt restructuring and recapitalization transaction of Foundever Group, a global integrated customer experience, digital operations and analytics services provider.
The transaction included, among other aspects, an extension of Foundever's revolving ... Show Full Article CHICAGO, Illinois, Aug. 25 [Category: BizLaw/Legal] -- Mayer Brown, a law firm, issued the following news: * * * Mayer Brown Advises Administrative Agent and Revolving Credit Lender Group on Foundever Group Recapitalization A cross-border Mayer Brown team advised the administrative agent and the revolving credit lender group in connection with a debt restructuring and recapitalization transaction of Foundever Group, a global integrated customer experience, digital operations and analytics services provider. The transaction included, among other aspects, an extension of Foundever's revolvingcredit facility with the consent of all revolving credit lenders, as well as a new three-year $225 million cross-border accounts receivable purchase program (ARPP) provided by certain revolving credit lenders to replace Foundever's prior factoring arrangement.
The transaction also included an equity capital contribution of $225 million by the equity owners of Foundever in connection with a reduction of Foundever's term loan facility.
The Mayer Brown team was led by New York partners Scott Zemser and Christophe Wassaf.
The ARPP aspects of the transaction were also led by Chicago and London partners Massimo Capretta, Patrick Healy and Charles Thain.
* * *
Original text here: https://www.mayerbrown.com/en/news/2026/08/mayer-brown-advises-administrative-agent-and-revolving-credit-lender-group-on-foundever-group-recapitalization
IHeartMedia and Oscar-Nominated Filmmaker Michael Epstein Launch "Fault Line: Haditha," a Weekly Limited-Series True Crime Podcast That Re-Examines One of the Most Controversial Incidents of the Iraq War
SAN ANTONIO, Texas, Aug. 25 -- iHeartMedia issued the following news release on Aug. 24, 2026:
* * *
iHeartMedia and Oscar-nominated Filmmaker Michael Epstein Launch "Fault Line: Haditha," a Weekly Limited-Series True Crime Podcast That Re-Examines One of the Most Controversial Incidents of the Iraq War
The 13-episode investigative series created in partnership with Crowd Network and High Road Entertainment delves into the killing of 24 Iraqi civilians by U.S. Marines
-
NEW YORK - iHeartPodcasts, the No. 1 podcast publisher according to Podtrac, and the Oscar-nominated filmmaker Michael Epstein ... Show Full Article SAN ANTONIO, Texas, Aug. 25 -- iHeartMedia issued the following news release on Aug. 24, 2026: * * * iHeartMedia and Oscar-nominated Filmmaker Michael Epstein Launch "Fault Line: Haditha," a Weekly Limited-Series True Crime Podcast That Re-Examines One of the Most Controversial Incidents of the Iraq War The 13-episode investigative series created in partnership with Crowd Network and High Road Entertainment delves into the killing of 24 Iraqi civilians by U.S. Marines - NEW YORK - iHeartPodcasts, the No. 1 podcast publisher according to Podtrac, and the Oscar-nominated filmmaker Michael Epsteintoday announced the launch of "Fault Line: Haditha," a 13-episode investigative podcast and companion documentary series that re-examines one of the most controversial incidents of the Iraq War and the two-decade fight over what happened, who should be held accountable and whether the full truth was ever allowed to emerge.
On November 19, 2005, 24 Iraqi civilians were killed by U.S. Marines in the city of Haditha. The killings would become the subject of the longest and most expensive criminal investigation in U.S. military history, drawing international scrutiny and raising questions about accountability within the military.
At the center of "Fault Line: Haditha" is former NCIS Special Agent Michael Maloney, who was assigned to investigate the killings. As Maloney pursued the case, he encountered political pressure, disputed testimony and what he came to believe were efforts by senior officials to undermine the investigation. His pursuit of the case would ultimately come at a significant cost to his career.
Twenty years later, Epstein returns to Haditha to examine what happened and what followed. Produced in collaboration with Crowd Network and High Road Entertainment, the series draws on years of reporting, documentary footage and extensive interviews to reconstruct the killings, the NCIS investigation, the subsequent legal proceedings and the lasting impact on the Marines involved and the Iraqi families whose lives were changed that day.
Each podcast episode will be accompanied by an original film on YouTube featuring extended scenes, archival material and interviews that expand upon the audio investigation. The footage includes interviews with Marines involved in the incident, NCIS investigators who worked the case and the sole surviving Iraqi eyewitness, who lost members of her family in the killings.
"This is a new kind of storytelling, a serialized investigation you hear on a podcast and then watch on YouTube. This isn't just a video version of the audio. These are two distinct experiences that complement each other," said Epstein. "As a filmmaker and a journalist, the most exciting thing for me is that there is no gatekeeper. I am able to take my investigation and all the revelations I've uncovered directly to a global audience."
Epstein is an Academy Award-nominated documentary filmmaker and podcast producer whose work has earned two George Foster Peabody Awards, two Primetime Emmy Awards and a Writers Guild of America Award. His films have screened at the Sundance Film Festival, Berlin International Film Festival, Toronto International Film Festival and New York Film Festival. His credits include "The Battle Over Citizen Kane," "LENNONYC" and "John & Yoko: Above Us Only Sky." His 2020 investigative podcast "Murder in House Two" reached No. 1 on Apple Podcasts' True Crime chart in the UK.
"'Fault Line: Haditha' represents the kind of ambitious investigative storytelling that podcasts are uniquely suited to deliver," said Will Pearson, President of iHeartPodcasts. "Michael has spent years examining this story, bringing together firsthand accounts, extensive reporting and remarkable access to revisit questions that have remained unresolved for two decades. We're proud to partner with Michael, Crowd Network and High Road Entertainment to bring this important investigation to audiences across both audio and video."
"Over the last two decades, there have been hundreds of reported stories that sought to tell the truth of what happened in Haditha," said Michael Carr, CEO, Crowd Network. "But Michael approached this tragedy differently. He never stopped questioning. He never stopped searching for the truth. His relentless passion and gift for storytelling reveal themselves not only in this podcast, but in the companion films that let audiences see this story, not just hear it."
"Michael and I have worked together on this story of Haditha for many years now, driven by a shared vision of getting it heard as far and wide as possible," said Richard Tulk-Hart, co-CEO, High Road Entertainment. "The more recent developments of this highly emotional and complex case have allowed for the podcast to come together in this unique format combining audio and documentary footage, and iHeart's support has been instrumental. Conversations are now underway to bring the remarkable story to our screens, continuing to allow these voices to be heard."
"Fault Line: Haditha" is distributed by iHeartPodcasts and is available on the iHeartRadio app and everywhere podcasts are heard. Video episodes will be available on YouTube.
* * *
About Michael Epstein
Michael Epstein is an Academy Award-nominated documentary filmmaker and podcast producer whose work has been awarded two George Foster Peabody Awards, two Primetime Emmys, a Writers Guild of America Award, a Clio, and numerous other honors. His films have been screened at dozens of international festivals, including the Sundance Film Festival, the Berlinale, the Toronto International Film Festival, and the New York Film Festival. His first documentary film, The Battle Over Citizen Kane, was awarded a Peabody and nominated for an Academy Award for Best Documentary Feature. Epstein's other work includes Combat Diary (Primetime Emmy nomination), LENNONYC (Peabody and Primetime Emmy Awards), and John & Yoko: Above Us Only Sky (International Emmy nomination). Epstein's original podcast series, "Murder in House Two," was released in 2020 and became the #1 True Crime podcast (Apple) in the UK.
* * *
About Crowd Network
Crowd Network is a multi-platform content company creating and commercialising talent-led brands across sport, entertainment, and culture. Founded in 2020 and based in Manchester, England, Crowd works with some of the world's leading athletes, broadcasters, and creators to build content brands that live across YouTube, social, audio, and live experiences. Its portfolio includes the For the Love network of sports content brands, alongside partnerships with major global brands and organisations.
* * *
About High Road Entertainment
High Road Entertainment is a scripted production and advisory company founded by Richard Tulk-Hart, former co-CEO of Buccaneer, and James Durie, former head of scripted television at Cineflix Rights. The company has its own slate of film and Television in development and recently helped set up BBC/Masterpiece series, "Portrait of a Lady" as well as "Mavis" for ITV. It is involved in multiple co-productions across the UK, US and International markets and represents a variety of high-end production companies. High Road also advises scripted producers on financing and distribution.
* * *
About iHeartMedia, Inc.
iHeartMedia, Inc. [Nasdaq: IHRT] is the leading audio media company in America, with nine out of ten Americans listening to iHeart broadcast radio in every month. iHeart's broadcast radio assets alone have a larger audience in the U.S. than any other media outlet and over four times the ad-enabled audience of the largest digital only audio service. iHeart is the largest podcast publisher according to both Podtrac and Triton, with more downloads than the next two podcast publishers combined, has the most recognizable live events across all genres of music, has the number one social footprint among audio players, has the highest-reach and most engaged influencers, and is the only fully integrated audio ad tech solution across broadcast, streaming and podcasts. The company continues to leverage its strong audience connection and unparalleled consumer reach to build new platforms, products and services. Visit iHeartMedia.com for more company information.
* * *
URL: Crowd Network
URL: High Road Entertainment
* * *
Original text here: https://www.iheartmedia.com/press/iheartmedia-and-oscar-nominated-filmmaker-michael-epstein-launch-fault-line-haditha-weekly
[Category: BizMedia]
* * *
iHeartMedia and Oscar-nominated Filmmaker Michael Epstein Launch "Fault Line: Haditha," a Weekly Limited-Series True Crime Podcast That Re-Examines One of the Most Controversial Incidents of the Iraq War
The 13-episode investigative series created in partnership with Crowd Network and High Road Entertainment delves into the killing of 24 Iraqi civilians by U.S. Marines
-
NEW YORK - iHeartPodcasts, the No. 1 podcast publisher according to Podtrac, and the Oscar-nominated filmmaker Michael Epstein ... Show Full Article SAN ANTONIO, Texas, Aug. 25 -- iHeartMedia issued the following news release on Aug. 24, 2026: * * * iHeartMedia and Oscar-nominated Filmmaker Michael Epstein Launch "Fault Line: Haditha," a Weekly Limited-Series True Crime Podcast That Re-Examines One of the Most Controversial Incidents of the Iraq War The 13-episode investigative series created in partnership with Crowd Network and High Road Entertainment delves into the killing of 24 Iraqi civilians by U.S. Marines - NEW YORK - iHeartPodcasts, the No. 1 podcast publisher according to Podtrac, and the Oscar-nominated filmmaker Michael Epsteintoday announced the launch of "Fault Line: Haditha," a 13-episode investigative podcast and companion documentary series that re-examines one of the most controversial incidents of the Iraq War and the two-decade fight over what happened, who should be held accountable and whether the full truth was ever allowed to emerge.
On November 19, 2005, 24 Iraqi civilians were killed by U.S. Marines in the city of Haditha. The killings would become the subject of the longest and most expensive criminal investigation in U.S. military history, drawing international scrutiny and raising questions about accountability within the military.
At the center of "Fault Line: Haditha" is former NCIS Special Agent Michael Maloney, who was assigned to investigate the killings. As Maloney pursued the case, he encountered political pressure, disputed testimony and what he came to believe were efforts by senior officials to undermine the investigation. His pursuit of the case would ultimately come at a significant cost to his career.
Twenty years later, Epstein returns to Haditha to examine what happened and what followed. Produced in collaboration with Crowd Network and High Road Entertainment, the series draws on years of reporting, documentary footage and extensive interviews to reconstruct the killings, the NCIS investigation, the subsequent legal proceedings and the lasting impact on the Marines involved and the Iraqi families whose lives were changed that day.
Each podcast episode will be accompanied by an original film on YouTube featuring extended scenes, archival material and interviews that expand upon the audio investigation. The footage includes interviews with Marines involved in the incident, NCIS investigators who worked the case and the sole surviving Iraqi eyewitness, who lost members of her family in the killings.
"This is a new kind of storytelling, a serialized investigation you hear on a podcast and then watch on YouTube. This isn't just a video version of the audio. These are two distinct experiences that complement each other," said Epstein. "As a filmmaker and a journalist, the most exciting thing for me is that there is no gatekeeper. I am able to take my investigation and all the revelations I've uncovered directly to a global audience."
Epstein is an Academy Award-nominated documentary filmmaker and podcast producer whose work has earned two George Foster Peabody Awards, two Primetime Emmy Awards and a Writers Guild of America Award. His films have screened at the Sundance Film Festival, Berlin International Film Festival, Toronto International Film Festival and New York Film Festival. His credits include "The Battle Over Citizen Kane," "LENNONYC" and "John & Yoko: Above Us Only Sky." His 2020 investigative podcast "Murder in House Two" reached No. 1 on Apple Podcasts' True Crime chart in the UK.
"'Fault Line: Haditha' represents the kind of ambitious investigative storytelling that podcasts are uniquely suited to deliver," said Will Pearson, President of iHeartPodcasts. "Michael has spent years examining this story, bringing together firsthand accounts, extensive reporting and remarkable access to revisit questions that have remained unresolved for two decades. We're proud to partner with Michael, Crowd Network and High Road Entertainment to bring this important investigation to audiences across both audio and video."
"Over the last two decades, there have been hundreds of reported stories that sought to tell the truth of what happened in Haditha," said Michael Carr, CEO, Crowd Network. "But Michael approached this tragedy differently. He never stopped questioning. He never stopped searching for the truth. His relentless passion and gift for storytelling reveal themselves not only in this podcast, but in the companion films that let audiences see this story, not just hear it."
"Michael and I have worked together on this story of Haditha for many years now, driven by a shared vision of getting it heard as far and wide as possible," said Richard Tulk-Hart, co-CEO, High Road Entertainment. "The more recent developments of this highly emotional and complex case have allowed for the podcast to come together in this unique format combining audio and documentary footage, and iHeart's support has been instrumental. Conversations are now underway to bring the remarkable story to our screens, continuing to allow these voices to be heard."
"Fault Line: Haditha" is distributed by iHeartPodcasts and is available on the iHeartRadio app and everywhere podcasts are heard. Video episodes will be available on YouTube.
* * *
About Michael Epstein
Michael Epstein is an Academy Award-nominated documentary filmmaker and podcast producer whose work has been awarded two George Foster Peabody Awards, two Primetime Emmys, a Writers Guild of America Award, a Clio, and numerous other honors. His films have been screened at dozens of international festivals, including the Sundance Film Festival, the Berlinale, the Toronto International Film Festival, and the New York Film Festival. His first documentary film, The Battle Over Citizen Kane, was awarded a Peabody and nominated for an Academy Award for Best Documentary Feature. Epstein's other work includes Combat Diary (Primetime Emmy nomination), LENNONYC (Peabody and Primetime Emmy Awards), and John & Yoko: Above Us Only Sky (International Emmy nomination). Epstein's original podcast series, "Murder in House Two," was released in 2020 and became the #1 True Crime podcast (Apple) in the UK.
* * *
About Crowd Network
Crowd Network is a multi-platform content company creating and commercialising talent-led brands across sport, entertainment, and culture. Founded in 2020 and based in Manchester, England, Crowd works with some of the world's leading athletes, broadcasters, and creators to build content brands that live across YouTube, social, audio, and live experiences. Its portfolio includes the For the Love network of sports content brands, alongside partnerships with major global brands and organisations.
* * *
About High Road Entertainment
High Road Entertainment is a scripted production and advisory company founded by Richard Tulk-Hart, former co-CEO of Buccaneer, and James Durie, former head of scripted television at Cineflix Rights. The company has its own slate of film and Television in development and recently helped set up BBC/Masterpiece series, "Portrait of a Lady" as well as "Mavis" for ITV. It is involved in multiple co-productions across the UK, US and International markets and represents a variety of high-end production companies. High Road also advises scripted producers on financing and distribution.
* * *
About iHeartMedia, Inc.
iHeartMedia, Inc. [Nasdaq: IHRT] is the leading audio media company in America, with nine out of ten Americans listening to iHeart broadcast radio in every month. iHeart's broadcast radio assets alone have a larger audience in the U.S. than any other media outlet and over four times the ad-enabled audience of the largest digital only audio service. iHeart is the largest podcast publisher according to both Podtrac and Triton, with more downloads than the next two podcast publishers combined, has the most recognizable live events across all genres of music, has the number one social footprint among audio players, has the highest-reach and most engaged influencers, and is the only fully integrated audio ad tech solution across broadcast, streaming and podcasts. The company continues to leverage its strong audience connection and unparalleled consumer reach to build new platforms, products and services. Visit iHeartMedia.com for more company information.
* * *
URL: Crowd Network
URL: High Road Entertainment
* * *
Original text here: https://www.iheartmedia.com/press/iheartmedia-and-oscar-nominated-filmmaker-michael-epstein-launch-fault-line-haditha-weekly
[Category: BizMedia]
GSK: Hibsago Approved in Japan as First and Only Functional Cure for Chronic Hepatitis B
LONDON, England, Aug. 25 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Aug. 24, 2026:
* * *
Hibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B
* First global approval for Hibsago
* Chronic hepatitis B affects nearly one million people in Japan/1 with nationwide efforts for screening and treatment2
* Approval accelerated by SENKU designation, granted to innovative medicines with potential to address high unmet medical need3
-
GSK plc (LSE/NYSE: GSK) today announced that Japan's Ministry ... Show Full Article LONDON, England, Aug. 25 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Aug. 24, 2026: * * * Hibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B * First global approval for Hibsago * Chronic hepatitis B affects nearly one million people in Japan/1 with nationwide efforts for screening and treatment2 * Approval accelerated by SENKU designation, granted to innovative medicines with potential to address high unmet medical need3 - GSK plc (LSE/NYSE: GSK) today announced that Japan's Ministryof Health, Labour and Welfare (MHLW) has approved Hibsago (bepirovirsen), an antisense oligonucleotide (ASO), as a functional cure for chronic hepatitis B (CHB) virus infection in adult patients who have received at least 6 months of prior nucleos(t)ide analogue therapy and meet pre-defined viral markersi. This is the first global approval for bepirovirsen, and the first and only functional cure treatment for CHB approved in Japan.
CHB is a major public health challenge and a leading cause of liver cancer globally./4 In Japan, nearly one million people live with the disease and it contributes to around 4,000 deaths annually./1 The Japanese government has demonstrated strong commitment to tackling CHB including through nationwide screening and treatment programmes./2
Tony Wood, Chief Scientific Officer, GSK, said: "For the first time, a treatment approved for functional cure is available to people living with chronic hepatitis B in Japan with Hibsago. After 6-months of treatment with Hibsago, patients could be freed from life-long therapy/5 and reduce their risk of long-term liver complications. This is a major advance for CHB management and our innovative hepatology portfolio, and we look forward to further regulatory decisions in other countries."
Approval in Japan was supported by results from the B-Well phase III trials showing unprecedented functional cure rates of 19% in adults with 3000 IU/ml HBsAg, compared to current standard of care alone which typically only achieves a 1% functional cure rate after one year of treatment./6 Functional cure occurs when the hepatitis B virus DNA and viral protein - HBsAg - are undetectable for at least 24 weeks after stopping all treatment. This indicates the disease is controlled by the immune system without medication. A loss in HBsAg is associated with up to an 89% reduction in risk of liver cancer and a 62% reduction in risk of all-cause mortality./7
This approval was accelerated by SENKU designation, granted to innovative medicines with potential to address high unmet medical need./3
GSK continues to advance regulatory submissions for bepirovirsen across multiple geographies with decisions, including the US, expected in the coming months. Development of bepirovirsen in future sequential treatment strategies is also ongoing.
Results from the B-Well phase III trials
Pooled data from the B-Well phase III trials showed that 6-month treatment with bepirovirsen achieved a statistically significant and clinically meaningful 19% functional cure response rate (233 of 1,220 vs. 0 of 614 in the placebo group; p<0.001 in both trials) in the overall study population (adults with 3000 IU/ml HBsAg level), meeting the primary endpoint. In a key secondary endpoint, a functional cure rate of 26% (200 of 768 vs. 0 of 393 in the placebo group; p<0.001 in both trials) was achieved in participants with 1000 IU/ml HBsAg level, a group that represents approximately 45% of diagnosed CHB cases globally./8
Separately, exploratory analyses showed bepirovirsen reduced HBsAg to 100 IU/ml in 49% of recipients (598 of 1220) in the overall study population and in 62% of recipients in the 1000 IU/ml (476 of 768) sub-group/9 as of the week 72 visit. Medical literature has linked this level of low surface antigen with increased immune control and improved patient outcomes./10,11,12
The trials showed an acceptable safety and tolerability profile consistent with other studies of bepirovirsen. The three most frequently observed adverse events were injection site erythema, local pain and temporary rise in the blood level of a liver enzyme.
* * *
About bepirovirsen
Bepirovirsen is an antisense oligonucleotide (ASO) designed to recognise and inhibit the production of the genetic components (i.e. RNA) of the hepatitis B virus that can lead to chronic disease, potentially allowing a person's immune system to regain control. Bepirovirsen reduces the production of RNA and viral proteins associated with HBV, suppresses the level of hepatitis B surface antigen (HBsAg) in the blood, and stimulates the immune system to increase the chances of a durable and sustained response.
GSK licensed bepirovirsen from Ionis and collaborated with them on its development. Bepirovirsen has been recognised by global regulatory authorities for its innovation and potential to address significant unmet need in hepatitis B, with Fast Track and Breakthrough Designations from the US FDA, Breakthrough Therapy and Priority Review designation in China and SENKU designation in Japan.
* * *
About the B-Well trials
The B-Well 1 and B-Well 2 trials are global multi-centre, randomised, double-blind, placebo-controlled trials conducted in 29 countries. They assessed the efficacy, safety, pharmacokinetic profile, and durability of functional cure in nucleos(t)ide analogue-treated adult participants with chronic hepatitis B and baseline surface antigen (HBsAg) 3000 IU/ml. The primary endpoint assessed the proportion of participants achieving functional cure in patients with baseline HBsAg 3000 IU/ml. A key ranked secondary endpoint evaluated functional cure in participants with baseline HBsAg 1000 IU/ml. Functional cure is defined as HBsAg being undetectable in the blood for at least 24 weeks after stopping all treatment, indicating that the disease is controlled by the immune system without medication.
* * *
About chronic hepatitis B
Hepatitis B is a viral infection that can cause both acute and chronic liver disease. Chronic hepatitis B occurs when the immune system is unable to clear the virus, resulting in long-lasting infection that affects more than 240 million people worldwide. The disease causes approximately 1.1 million deaths each year13, and is a leading cause of liver cancer cases globally4. Currently, many patients often require lifelong antiviral therapy for viral suppression, making functional cure a critical goal in disease management.
* * *
About GSK's hepatology portfolio
GSK is extending its expertise in inflammation to develop a next wave of innovation for the millions of people affected by chronic and life-threatening fibro-inflammatory liver conditions. GSK has a growing hepatology pipeline, harnessed by the science of the immune system and advanced technologies, with a focus on chronic hepatitis B, metabolic dysfunction-associated steatohepatitis (MASH) and alcohol-associated liver disease (ALD).
* * *
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
* * *
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2025, and GSK's Q2 Results for 2026.
* * *
Footnote
[i] Hibsago (bepirovirsen) has been approved as a functional cure in chronic hepatitis B (CHB) virus infection in patients who have received nucleos (t) ide analogue therapy for at least 6 months before starting this drug and whose HBs antigen level at starting this drug is 3000 IU/mL and HBV DNA level is < 90 IU/mL (1.95logIU/mL).
* * *
References
1. Polaris Observatory Dashboard. Available at https://cdafound.org/polaris/dashboard (last accessed August 2026)
2. Korenaga M, Kanto T. Testing, diagnosis of viral hepatitis, and the follow-up policy in Japan. Glob Health Med. 2021 Oct 31;3(5):308-313. doi: 10.35772/ghm.2021.01072. PMID: 34782874; PMCID: PMC8562087.
3. GSK Press release, Bepirovirsen granted SENKU designation in Japan for chronic hepatitis B, August 2024. Available at: https://www.gsk.com/en-gb/media/press-releases/bepirovirsen-granted-senku-designation-in-japan-for-chronic-hepatitis-b/ (last accessed July 2026)
4. Rumgay H et al . Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598-1606. doi: 10.1016/j.jhep.2022.08.021
5. Hou J, Lim S-G, Buti M, et al. Phase 3 results of bepirovirsen treatment for chronic hepatitis B virus infection. N Engl J Med 2026;394:2395-406. DOI: 10.1056/NEJMoa2515131
6. Slaets, L. et al. "Systematic review with meta-analysis: hepatitis B surface antigen decline and seroclearance in chronic hepatitis B patients on nucleos(t)ide analogues or pegylated interferon therapy" in GastroHep 2, 106-116 (2020)
7. Drysdale M, Chang R, Wang S, Coutinho A, Gielen V, Man T, Song R, Duh MS, Khalili M, Theodore D. Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in US Individuals With Chronic Hepatitis B Virus Infection. J Viral Hepat. 2026 Jun;33(6):e70184. doi: 10.1111/jvh.70184. PMID: 42141794; PMCID: PMC13179525.
8. GSK data on file, 2026
9. Hou J, EASL 2026. Oral presentation. Slides available upon request.
10. Tseng TC et al. Gut 2025;74:1896-1906
11. Zhou K et al. Lancet Gastroenterol Hepatol 2019;4:227-238
12. Tseng TC et al. Hepatology 2012;55:68-76
13. WHO Global Hepatitis Report 2026. Available at : https://www.who.int/publications/i/item/9789240122383 (last accessed August 2026)
* * *
Original text here: https://www.gsk.com/en-gb/media/press-releases/hibsago-bepirovirsen-approved-in-japan-as-first-and-only-functional-cure-for-chronic-hepatitis-b/
[Category: BizPharmaceuticals]
* * *
Hibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B
* First global approval for Hibsago
* Chronic hepatitis B affects nearly one million people in Japan/1 with nationwide efforts for screening and treatment2
* Approval accelerated by SENKU designation, granted to innovative medicines with potential to address high unmet medical need3
-
GSK plc (LSE/NYSE: GSK) today announced that Japan's Ministry ... Show Full Article LONDON, England, Aug. 25 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Aug. 24, 2026: * * * Hibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B * First global approval for Hibsago * Chronic hepatitis B affects nearly one million people in Japan/1 with nationwide efforts for screening and treatment2 * Approval accelerated by SENKU designation, granted to innovative medicines with potential to address high unmet medical need3 - GSK plc (LSE/NYSE: GSK) today announced that Japan's Ministryof Health, Labour and Welfare (MHLW) has approved Hibsago (bepirovirsen), an antisense oligonucleotide (ASO), as a functional cure for chronic hepatitis B (CHB) virus infection in adult patients who have received at least 6 months of prior nucleos(t)ide analogue therapy and meet pre-defined viral markersi. This is the first global approval for bepirovirsen, and the first and only functional cure treatment for CHB approved in Japan.
CHB is a major public health challenge and a leading cause of liver cancer globally./4 In Japan, nearly one million people live with the disease and it contributes to around 4,000 deaths annually./1 The Japanese government has demonstrated strong commitment to tackling CHB including through nationwide screening and treatment programmes./2
Tony Wood, Chief Scientific Officer, GSK, said: "For the first time, a treatment approved for functional cure is available to people living with chronic hepatitis B in Japan with Hibsago. After 6-months of treatment with Hibsago, patients could be freed from life-long therapy/5 and reduce their risk of long-term liver complications. This is a major advance for CHB management and our innovative hepatology portfolio, and we look forward to further regulatory decisions in other countries."
Approval in Japan was supported by results from the B-Well phase III trials showing unprecedented functional cure rates of 19% in adults with 3000 IU/ml HBsAg, compared to current standard of care alone which typically only achieves a 1% functional cure rate after one year of treatment./6 Functional cure occurs when the hepatitis B virus DNA and viral protein - HBsAg - are undetectable for at least 24 weeks after stopping all treatment. This indicates the disease is controlled by the immune system without medication. A loss in HBsAg is associated with up to an 89% reduction in risk of liver cancer and a 62% reduction in risk of all-cause mortality./7
This approval was accelerated by SENKU designation, granted to innovative medicines with potential to address high unmet medical need./3
GSK continues to advance regulatory submissions for bepirovirsen across multiple geographies with decisions, including the US, expected in the coming months. Development of bepirovirsen in future sequential treatment strategies is also ongoing.
Results from the B-Well phase III trials
Pooled data from the B-Well phase III trials showed that 6-month treatment with bepirovirsen achieved a statistically significant and clinically meaningful 19% functional cure response rate (233 of 1,220 vs. 0 of 614 in the placebo group; p<0.001 in both trials) in the overall study population (adults with 3000 IU/ml HBsAg level), meeting the primary endpoint. In a key secondary endpoint, a functional cure rate of 26% (200 of 768 vs. 0 of 393 in the placebo group; p<0.001 in both trials) was achieved in participants with 1000 IU/ml HBsAg level, a group that represents approximately 45% of diagnosed CHB cases globally./8
Separately, exploratory analyses showed bepirovirsen reduced HBsAg to 100 IU/ml in 49% of recipients (598 of 1220) in the overall study population and in 62% of recipients in the 1000 IU/ml (476 of 768) sub-group/9 as of the week 72 visit. Medical literature has linked this level of low surface antigen with increased immune control and improved patient outcomes./10,11,12
The trials showed an acceptable safety and tolerability profile consistent with other studies of bepirovirsen. The three most frequently observed adverse events were injection site erythema, local pain and temporary rise in the blood level of a liver enzyme.
* * *
About bepirovirsen
Bepirovirsen is an antisense oligonucleotide (ASO) designed to recognise and inhibit the production of the genetic components (i.e. RNA) of the hepatitis B virus that can lead to chronic disease, potentially allowing a person's immune system to regain control. Bepirovirsen reduces the production of RNA and viral proteins associated with HBV, suppresses the level of hepatitis B surface antigen (HBsAg) in the blood, and stimulates the immune system to increase the chances of a durable and sustained response.
GSK licensed bepirovirsen from Ionis and collaborated with them on its development. Bepirovirsen has been recognised by global regulatory authorities for its innovation and potential to address significant unmet need in hepatitis B, with Fast Track and Breakthrough Designations from the US FDA, Breakthrough Therapy and Priority Review designation in China and SENKU designation in Japan.
* * *
About the B-Well trials
The B-Well 1 and B-Well 2 trials are global multi-centre, randomised, double-blind, placebo-controlled trials conducted in 29 countries. They assessed the efficacy, safety, pharmacokinetic profile, and durability of functional cure in nucleos(t)ide analogue-treated adult participants with chronic hepatitis B and baseline surface antigen (HBsAg) 3000 IU/ml. The primary endpoint assessed the proportion of participants achieving functional cure in patients with baseline HBsAg 3000 IU/ml. A key ranked secondary endpoint evaluated functional cure in participants with baseline HBsAg 1000 IU/ml. Functional cure is defined as HBsAg being undetectable in the blood for at least 24 weeks after stopping all treatment, indicating that the disease is controlled by the immune system without medication.
* * *
About chronic hepatitis B
Hepatitis B is a viral infection that can cause both acute and chronic liver disease. Chronic hepatitis B occurs when the immune system is unable to clear the virus, resulting in long-lasting infection that affects more than 240 million people worldwide. The disease causes approximately 1.1 million deaths each year13, and is a leading cause of liver cancer cases globally4. Currently, many patients often require lifelong antiviral therapy for viral suppression, making functional cure a critical goal in disease management.
* * *
About GSK's hepatology portfolio
GSK is extending its expertise in inflammation to develop a next wave of innovation for the millions of people affected by chronic and life-threatening fibro-inflammatory liver conditions. GSK has a growing hepatology pipeline, harnessed by the science of the immune system and advanced technologies, with a focus on chronic hepatitis B, metabolic dysfunction-associated steatohepatitis (MASH) and alcohol-associated liver disease (ALD).
* * *
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
* * *
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2025, and GSK's Q2 Results for 2026.
* * *
Footnote
[i] Hibsago (bepirovirsen) has been approved as a functional cure in chronic hepatitis B (CHB) virus infection in patients who have received nucleos (t) ide analogue therapy for at least 6 months before starting this drug and whose HBs antigen level at starting this drug is 3000 IU/mL and HBV DNA level is < 90 IU/mL (1.95logIU/mL).
* * *
References
1. Polaris Observatory Dashboard. Available at https://cdafound.org/polaris/dashboard (last accessed August 2026)
2. Korenaga M, Kanto T. Testing, diagnosis of viral hepatitis, and the follow-up policy in Japan. Glob Health Med. 2021 Oct 31;3(5):308-313. doi: 10.35772/ghm.2021.01072. PMID: 34782874; PMCID: PMC8562087.
3. GSK Press release, Bepirovirsen granted SENKU designation in Japan for chronic hepatitis B, August 2024. Available at: https://www.gsk.com/en-gb/media/press-releases/bepirovirsen-granted-senku-designation-in-japan-for-chronic-hepatitis-b/ (last accessed July 2026)
4. Rumgay H et al . Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598-1606. doi: 10.1016/j.jhep.2022.08.021
5. Hou J, Lim S-G, Buti M, et al. Phase 3 results of bepirovirsen treatment for chronic hepatitis B virus infection. N Engl J Med 2026;394:2395-406. DOI: 10.1056/NEJMoa2515131
6. Slaets, L. et al. "Systematic review with meta-analysis: hepatitis B surface antigen decline and seroclearance in chronic hepatitis B patients on nucleos(t)ide analogues or pegylated interferon therapy" in GastroHep 2, 106-116 (2020)
7. Drysdale M, Chang R, Wang S, Coutinho A, Gielen V, Man T, Song R, Duh MS, Khalili M, Theodore D. Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in US Individuals With Chronic Hepatitis B Virus Infection. J Viral Hepat. 2026 Jun;33(6):e70184. doi: 10.1111/jvh.70184. PMID: 42141794; PMCID: PMC13179525.
8. GSK data on file, 2026
9. Hou J, EASL 2026. Oral presentation. Slides available upon request.
10. Tseng TC et al. Gut 2025;74:1896-1906
11. Zhou K et al. Lancet Gastroenterol Hepatol 2019;4:227-238
12. Tseng TC et al. Hepatology 2012;55:68-76
13. WHO Global Hepatitis Report 2026. Available at : https://www.who.int/publications/i/item/9789240122383 (last accessed August 2026)
* * *
Original text here: https://www.gsk.com/en-gb/media/press-releases/hibsago-bepirovirsen-approved-in-japan-as-first-and-only-functional-cure-for-chronic-hepatitis-b/
[Category: BizPharmaceuticals]
Fisher Phillips Issues Insight: Feds Propose New Disclosure Rules for Personalized "Surveillance" Pricing
ATLANTA, Georgia, Aug. 25 -- Fisher Phillips, a law firm, issued the following Insight on Aug. 24, 2026:
* * *
Feds Propose New Disclosure Rules for Personalized "Surveillance" Pricing; Businesses Can Comment by Sept 18
The Federal Trade Commission just proposed a new policy that would require businesses to tell customers when they're being charged a different price than someone else for the same product based on that customer's personal data. The proposal, released August 19, targets what the FTC calls personalized pricing (the same practice often referred to as "surveillance" pricing), and ... Show Full Article ATLANTA, Georgia, Aug. 25 -- Fisher Phillips, a law firm, issued the following Insight on Aug. 24, 2026: * * * Feds Propose New Disclosure Rules for Personalized "Surveillance" Pricing; Businesses Can Comment by Sept 18 The Federal Trade Commission just proposed a new policy that would require businesses to tell customers when they're being charged a different price than someone else for the same product based on that customer's personal data. The proposal, released August 19, targets what the FTC calls personalized pricing (the same practice often referred to as "surveillance" pricing), andgives the public until September 18 to weigh in before it's finalized. For businesses in retail, delivery, hospitality, and e-commerce that already use dynamic or algorithm-driven pricing, the proposal explains exactly what FTC agents will look for during any investigation. What do you need to know - and do?
What the FTC is Proposing
The Commission's August 19 announcement acknowledges it lacks authority to prohibit personalized pricing across the board. Companies often offer varied pricing by consumer for legitimate reasons. These include insurance premiums that reflect individual risk, loan rates that reflect creditworthiness, and rideshare fares that shift with local supply and demand. But the FTC says the sheer volume of data companies now collect on individuals allows them to change the price on the shelf or the screen based on other factors unique to each consumer.
The FTC's position is that businesses using personalized pricing should clearly and conspicuously disclose three things:
* that the price is personalized
* the basis for the personalization, and
* the types of data used to set it
The Commission says that failing to do so likely constitutes an unfair or deceptive practice under Section 5 of the FTC Act.
FTC: "Special Price" Language Won't Be Enough
The proposed statement says you can't just tell a shopper they've received a "specially selected" or "personalized" price and nothing more without running afoul of the law. The agency said it would treat that as likely misleading because it omits the information a consumer would need to act on it.
By contrast, the FTC offers an example of adequate disclosure. If you accurately and completely tell a consumer that a price is based on their purchase history with your business, that would pass the agency's muster.
2 Legal Theories
The FTC says it will pursue personalized pricing issues under both of its core Section 5 theories:
* Deception. Representing or implying that a price is static or generally available when it's actually personalized, or misleading consumers about the basis or effect of that personalization, can support a deception claim.
* Unfairness. Even without an affirmative misrepresentation, concealing that a price is personalized can be unfair if it prevents consumers from taking steps to avoid a higher price, such as comparison shopping, using a different browser or device, or correcting inaccurate data being used against them.
The statement also notes that certain data handling practices related to personalized pricing could be within the FTC's sights for another reason. If you collect, use, or share consumer data to help fuel a personalized pricing model without adequate disclosure or consent, you could be separately violating the FTC Act's Section 5.
Examples of Potential Violations
The FTC's proposal includes a list of illustrative scenarios that would raise Section 5 concerns. Among the examples:
* a food delivery company charging more to consumers it believes are less able to leave their homes;
* a grocery chain charging more for delivered milk because data shows children live in the household;
* a hotel charging more because it infers a guest is traveling for a funeral; and
* a retailer raising a price when data shows the shopper is currently browsing from inside one of its own physical stores.
What Should You Do?
If your business is in retail, hospitality, delivery, ride-hailing, or e-commerce generally and you use dynamic, algorithmic, or data-driven pricing, consider taking these steps now:
1. Inventory your pricing models. Identify every place where price, discount, or fee amounts can vary based on data tied to an individual consumer, rather than a broad segment or a neutral factor like time or location.
2. Audit your disclosures. Compare existing consumer-facing language against the FTC's three-part standard: does it say the price is personalized, why, and what data was used? Generic "prices may vary" language probably won't be enough.
3. Trace your data consent chain. Confirm that any personal data feeding a pricing model was collected with sufficient disclosure and consent.
4. Watch how this interacts with your CIPA and surveillance pricing exposure. The data collection practices that power personalized pricing are the same practices driving the wave of digital wiretapping and surveillance pricing litigation we've been tracking.
5. Monitor federal and state legislative activity. We recently created an overview about legislative proposals across the country related to surveillance pricing. Take a look here and make sure you are tracking any laws that could impact your business.
6. Submit a comment before September 18. The FTC is accepting public comment on the proposed statement, and this is your opportunity to shape a finalized disclosure standard. Reach out to your Fisher Phillips attorney or our FP Gov Team for guidance on participating in the process.
Conclusion
Fisher Phillips will continue to monitor developments in this area. Make sure you are subscribed to Fisher Phillips' Insight System to get the most up-to-date information directly to your inbox. For further information, contact your Fisher Phillips attorney, the authors of this Insight, or anyone on our Privacy and Cyber Team.
* * *
Related People
Risa B. Boerner, CIPP/US, CIPM
Partner
610.230.2132
rboerner@fisherphillips.com
* * *
Usama Kahf, CIPP/US
Partner
949.798.2118
ukahf@fisherphillips.com
* * *
Danielle Kays
Partner
312.260.4751
dkays@fisherphillips.com
* * *
Original text here: https://www.fisherphillips.com/en/insights/insights/feds-propose-new-disclosure-rules-for-personalized-surveillance-pricing
[Category: BizLaw/Legal]
* * *
Feds Propose New Disclosure Rules for Personalized "Surveillance" Pricing; Businesses Can Comment by Sept 18
The Federal Trade Commission just proposed a new policy that would require businesses to tell customers when they're being charged a different price than someone else for the same product based on that customer's personal data. The proposal, released August 19, targets what the FTC calls personalized pricing (the same practice often referred to as "surveillance" pricing), and ... Show Full Article ATLANTA, Georgia, Aug. 25 -- Fisher Phillips, a law firm, issued the following Insight on Aug. 24, 2026: * * * Feds Propose New Disclosure Rules for Personalized "Surveillance" Pricing; Businesses Can Comment by Sept 18 The Federal Trade Commission just proposed a new policy that would require businesses to tell customers when they're being charged a different price than someone else for the same product based on that customer's personal data. The proposal, released August 19, targets what the FTC calls personalized pricing (the same practice often referred to as "surveillance" pricing), andgives the public until September 18 to weigh in before it's finalized. For businesses in retail, delivery, hospitality, and e-commerce that already use dynamic or algorithm-driven pricing, the proposal explains exactly what FTC agents will look for during any investigation. What do you need to know - and do?
What the FTC is Proposing
The Commission's August 19 announcement acknowledges it lacks authority to prohibit personalized pricing across the board. Companies often offer varied pricing by consumer for legitimate reasons. These include insurance premiums that reflect individual risk, loan rates that reflect creditworthiness, and rideshare fares that shift with local supply and demand. But the FTC says the sheer volume of data companies now collect on individuals allows them to change the price on the shelf or the screen based on other factors unique to each consumer.
The FTC's position is that businesses using personalized pricing should clearly and conspicuously disclose three things:
* that the price is personalized
* the basis for the personalization, and
* the types of data used to set it
The Commission says that failing to do so likely constitutes an unfair or deceptive practice under Section 5 of the FTC Act.
FTC: "Special Price" Language Won't Be Enough
The proposed statement says you can't just tell a shopper they've received a "specially selected" or "personalized" price and nothing more without running afoul of the law. The agency said it would treat that as likely misleading because it omits the information a consumer would need to act on it.
By contrast, the FTC offers an example of adequate disclosure. If you accurately and completely tell a consumer that a price is based on their purchase history with your business, that would pass the agency's muster.
2 Legal Theories
The FTC says it will pursue personalized pricing issues under both of its core Section 5 theories:
* Deception. Representing or implying that a price is static or generally available when it's actually personalized, or misleading consumers about the basis or effect of that personalization, can support a deception claim.
* Unfairness. Even without an affirmative misrepresentation, concealing that a price is personalized can be unfair if it prevents consumers from taking steps to avoid a higher price, such as comparison shopping, using a different browser or device, or correcting inaccurate data being used against them.
The statement also notes that certain data handling practices related to personalized pricing could be within the FTC's sights for another reason. If you collect, use, or share consumer data to help fuel a personalized pricing model without adequate disclosure or consent, you could be separately violating the FTC Act's Section 5.
Examples of Potential Violations
The FTC's proposal includes a list of illustrative scenarios that would raise Section 5 concerns. Among the examples:
* a food delivery company charging more to consumers it believes are less able to leave their homes;
* a grocery chain charging more for delivered milk because data shows children live in the household;
* a hotel charging more because it infers a guest is traveling for a funeral; and
* a retailer raising a price when data shows the shopper is currently browsing from inside one of its own physical stores.
What Should You Do?
If your business is in retail, hospitality, delivery, ride-hailing, or e-commerce generally and you use dynamic, algorithmic, or data-driven pricing, consider taking these steps now:
1. Inventory your pricing models. Identify every place where price, discount, or fee amounts can vary based on data tied to an individual consumer, rather than a broad segment or a neutral factor like time or location.
2. Audit your disclosures. Compare existing consumer-facing language against the FTC's three-part standard: does it say the price is personalized, why, and what data was used? Generic "prices may vary" language probably won't be enough.
3. Trace your data consent chain. Confirm that any personal data feeding a pricing model was collected with sufficient disclosure and consent.
4. Watch how this interacts with your CIPA and surveillance pricing exposure. The data collection practices that power personalized pricing are the same practices driving the wave of digital wiretapping and surveillance pricing litigation we've been tracking.
5. Monitor federal and state legislative activity. We recently created an overview about legislative proposals across the country related to surveillance pricing. Take a look here and make sure you are tracking any laws that could impact your business.
6. Submit a comment before September 18. The FTC is accepting public comment on the proposed statement, and this is your opportunity to shape a finalized disclosure standard. Reach out to your Fisher Phillips attorney or our FP Gov Team for guidance on participating in the process.
Conclusion
Fisher Phillips will continue to monitor developments in this area. Make sure you are subscribed to Fisher Phillips' Insight System to get the most up-to-date information directly to your inbox. For further information, contact your Fisher Phillips attorney, the authors of this Insight, or anyone on our Privacy and Cyber Team.
* * *
Related People
Risa B. Boerner, CIPP/US, CIPM
Partner
610.230.2132
rboerner@fisherphillips.com
* * *
Usama Kahf, CIPP/US
Partner
949.798.2118
ukahf@fisherphillips.com
* * *
Danielle Kays
Partner
312.260.4751
dkays@fisherphillips.com
* * *
Original text here: https://www.fisherphillips.com/en/insights/insights/feds-propose-new-disclosure-rules-for-personalized-surveillance-pricing
[Category: BizLaw/Legal]
FICO: UK Credit Card Payment Rates Drop and Card Balances Rise as Summer Spending Puts Pressure on Consumers
SAN JOSE, California, Aug. 25 -- FICO, an analytics software company, issued the following news:
* * *
UK Credit Card Payment Rates Drop and Card Balances Rise as Summer Spending Puts Pressure on Consumers
FICO UK Credit Card Market Report for June 2026 identifies the need for increased vigilance on late payments by risk teams
-
LONDON: As summer spending rose in June, credit card data analysis for June 2026 by global analytics software leader FICO (NYSE: FICO) underlines the financial pressures facing UK households. Falling payments contributed to an annual increase in accounts with one, ... Show Full Article SAN JOSE, California, Aug. 25 -- FICO, an analytics software company, issued the following news: * * * UK Credit Card Payment Rates Drop and Card Balances Rise as Summer Spending Puts Pressure on Consumers FICO UK Credit Card Market Report for June 2026 identifies the need for increased vigilance on late payments by risk teams - LONDON: As summer spending rose in June, credit card data analysis for June 2026 by global analytics software leader FICO (NYSE: FICO) underlines the financial pressures facing UK households. Falling payments contributed to an annual increase in accounts with one,two and three missed payments. And with average balances across all three delinquent categories rising month-on-month, risk teams will need to maintain heightened monitoring for signs of pressure on affordability.
Highlights
* Average spend increased by 5.6% month-on-month, to pound sterling835.
* The average active balance increased by 1.4% month-on-month, reaching a new record high of pound sterling1,975. It is also 4.7% higher than June 2025.
* The percentage of balance paid decreased by 2.4% month-on-month to 33.3%, and remaining 4.4% lower year-on-year.
* The percentage of customers missing one payment increased 7.7% year-on-year, with the average balance on accounts with one missed payment 4.1% higher
* There was a 5.5% increase, month-on-month, in customers missing two payments and 9.1% year-on-year, with the average balance increasing 2.2% year-on-year
* For customers missing three payments, there was a significant 14.3% year-on-year increase, with the average balance 1.9% higher than the same month in 2025.
* Average credit limits increased by 0.2% month-on-month to pound sterling5,985, remaining 2.0% higher year-on-year.
FICO Comment:
June 2026 continued to present a mixed picture for consumer affordability. An increase in spending could, potentially, be seen as a good sign of economic confidence, however, the increase in spending was not matched by the percentage of overall balance paid, which fell on the previous month and year, reversing the previous recovery and continuing its persistent downwards trend. And with an increase in late payments across one, two and three months, a record-high average active balance will be of concern to risk teams.
Payment rates remain at historically low levels, close to the pre-pandemic average of 30%. With rising spending and payments to balance, the average active balance has maintained record highs, a trend that characterised the market throughout 2025 and into 2026.
In terms of missed payments, June saw a mixed picture across delinquency categories, with month-on-month improvements in one and three-cycle accounts offset by an increase at two cycles. However, all three delinquency categories remain higher year-on-year, continuing the concerning trend that emerged in the second half of 2025 and has persisted throughout 2026.
June credit card data indicates that underlying affordability pressures remain significant. Risk teams should maintain heightened monitoring of delinquency progression through the cycle buckets and ensure pre-delinquency intervention strategies remain calibrated to address the elevated balance levels now characteristic of customers in financial difficulty.
Key Trend Indicators UK Cards - June 2026
Metric ... Amount ... Month-Month Change ... Year-Year Change
Average UK Credit Card Spend ... pound sterling835 ... +5.6% ... +0.9%
Average Card Balance ... pound sterling1,975 ... +1.4% ... +4.7%
Percentage of Payments to Balance ... 33.3% ... -2.4% ... -4.4%
Accounts with One Missed Payment ... 1.4% ... -7.7% ... +7.7%
Accounts with Two Missed Payments ... 0.3% ... +5.5% ... +9.1%
Accounts with Three Missed Payments ... 0.2% ... -13.9% ... +14.3%
Average Credit Limit ... pound sterling5,985 ... +0.2% ... +2.0%
Average Overlimit Spend ... pound sterling95 ... -4.1% ... +3.3%
Cash Sales as a % of Total Sales ... 0.8% ... +0.5% ... -4.4%
These card performance figures are part of the data shared with subscribers of the FICO(R) Benchmark Reporting Service. The data sample comes from client reports generated by the FICO(R) TRIAD(R) Customer Manager solution in use by some 80% of UK card issuers. For more information on these trends, contact FICO.
* * *
About FICO
FICO (NYSE: FICO) powers decisions that help people and businesses around the world prosper. Founded in 1956, the company is a pioneer in the use of predictive analytics and data science to improve operational decisions. FICO holds more than 200 US and foreign patents on technologies that increase profitability, customer satisfaction and growth for businesses in financial services, insurance, telecommunications, health care, retail and many other industries. Using FICO solutions, businesses in more than 80 countries do everything from protecting 4 billion payment cards from fraud, to improving financial inclusion, to increasing supply chain resiliency. The FICO(R) Score, used by 90% of top US lenders, is the standard measure of consumer credit risk in the US and has been made available in over 40 other countries, improving risk management, credit access and transparency. Learn more at www.fico.com.
FICO and TRIAD are registered trademarks of Fair Isaac Corporation in the United States and other countries.
* * *
Original text here: https://www.fico.com/en/newsroom/uk-credit-card-payment-rates-drop-and-card-balances-rise-summer-spending-puts-pressure-consumers
[Category: BizComputer Technology]
* * *
UK Credit Card Payment Rates Drop and Card Balances Rise as Summer Spending Puts Pressure on Consumers
FICO UK Credit Card Market Report for June 2026 identifies the need for increased vigilance on late payments by risk teams
-
LONDON: As summer spending rose in June, credit card data analysis for June 2026 by global analytics software leader FICO (NYSE: FICO) underlines the financial pressures facing UK households. Falling payments contributed to an annual increase in accounts with one, ... Show Full Article SAN JOSE, California, Aug. 25 -- FICO, an analytics software company, issued the following news: * * * UK Credit Card Payment Rates Drop and Card Balances Rise as Summer Spending Puts Pressure on Consumers FICO UK Credit Card Market Report for June 2026 identifies the need for increased vigilance on late payments by risk teams - LONDON: As summer spending rose in June, credit card data analysis for June 2026 by global analytics software leader FICO (NYSE: FICO) underlines the financial pressures facing UK households. Falling payments contributed to an annual increase in accounts with one,two and three missed payments. And with average balances across all three delinquent categories rising month-on-month, risk teams will need to maintain heightened monitoring for signs of pressure on affordability.
Highlights
* Average spend increased by 5.6% month-on-month, to pound sterling835.
* The average active balance increased by 1.4% month-on-month, reaching a new record high of pound sterling1,975. It is also 4.7% higher than June 2025.
* The percentage of balance paid decreased by 2.4% month-on-month to 33.3%, and remaining 4.4% lower year-on-year.
* The percentage of customers missing one payment increased 7.7% year-on-year, with the average balance on accounts with one missed payment 4.1% higher
* There was a 5.5% increase, month-on-month, in customers missing two payments and 9.1% year-on-year, with the average balance increasing 2.2% year-on-year
* For customers missing three payments, there was a significant 14.3% year-on-year increase, with the average balance 1.9% higher than the same month in 2025.
* Average credit limits increased by 0.2% month-on-month to pound sterling5,985, remaining 2.0% higher year-on-year.
FICO Comment:
June 2026 continued to present a mixed picture for consumer affordability. An increase in spending could, potentially, be seen as a good sign of economic confidence, however, the increase in spending was not matched by the percentage of overall balance paid, which fell on the previous month and year, reversing the previous recovery and continuing its persistent downwards trend. And with an increase in late payments across one, two and three months, a record-high average active balance will be of concern to risk teams.
Payment rates remain at historically low levels, close to the pre-pandemic average of 30%. With rising spending and payments to balance, the average active balance has maintained record highs, a trend that characterised the market throughout 2025 and into 2026.
In terms of missed payments, June saw a mixed picture across delinquency categories, with month-on-month improvements in one and three-cycle accounts offset by an increase at two cycles. However, all three delinquency categories remain higher year-on-year, continuing the concerning trend that emerged in the second half of 2025 and has persisted throughout 2026.
June credit card data indicates that underlying affordability pressures remain significant. Risk teams should maintain heightened monitoring of delinquency progression through the cycle buckets and ensure pre-delinquency intervention strategies remain calibrated to address the elevated balance levels now characteristic of customers in financial difficulty.
Key Trend Indicators UK Cards - June 2026
Metric ... Amount ... Month-Month Change ... Year-Year Change
Average UK Credit Card Spend ... pound sterling835 ... +5.6% ... +0.9%
Average Card Balance ... pound sterling1,975 ... +1.4% ... +4.7%
Percentage of Payments to Balance ... 33.3% ... -2.4% ... -4.4%
Accounts with One Missed Payment ... 1.4% ... -7.7% ... +7.7%
Accounts with Two Missed Payments ... 0.3% ... +5.5% ... +9.1%
Accounts with Three Missed Payments ... 0.2% ... -13.9% ... +14.3%
Average Credit Limit ... pound sterling5,985 ... +0.2% ... +2.0%
Average Overlimit Spend ... pound sterling95 ... -4.1% ... +3.3%
Cash Sales as a % of Total Sales ... 0.8% ... +0.5% ... -4.4%
These card performance figures are part of the data shared with subscribers of the FICO(R) Benchmark Reporting Service. The data sample comes from client reports generated by the FICO(R) TRIAD(R) Customer Manager solution in use by some 80% of UK card issuers. For more information on these trends, contact FICO.
* * *
About FICO
FICO (NYSE: FICO) powers decisions that help people and businesses around the world prosper. Founded in 1956, the company is a pioneer in the use of predictive analytics and data science to improve operational decisions. FICO holds more than 200 US and foreign patents on technologies that increase profitability, customer satisfaction and growth for businesses in financial services, insurance, telecommunications, health care, retail and many other industries. Using FICO solutions, businesses in more than 80 countries do everything from protecting 4 billion payment cards from fraud, to improving financial inclusion, to increasing supply chain resiliency. The FICO(R) Score, used by 90% of top US lenders, is the standard measure of consumer credit risk in the US and has been made available in over 40 other countries, improving risk management, credit access and transparency. Learn more at www.fico.com.
FICO and TRIAD are registered trademarks of Fair Isaac Corporation in the United States and other countries.
* * *
Original text here: https://www.fico.com/en/newsroom/uk-credit-card-payment-rates-drop-and-card-balances-rise-summer-spending-puts-pressure-consumers
[Category: BizComputer Technology]
American Airlines Celebrates Expanded Access to Flagship Dining With Exclusive Offering From KHK Wines and K+M Extravirgin Chocolate Pairing Curated by Chef Thomas Keller
FORT WORTH, Texas, Aug. 25 -- American Airlines posted the following news:
* * *
American Airlines celebrates expanded access to Flagship Dining with exclusive offering from KHK Wines and K+M Extravirgin Chocolate pairing curated by Chef Thomas Keller
* American Airlines expands Flagship(R) Dining access, bringing its premium sit-down dining experience to more eligible customers at DFW and MIA beginning Sept. 15, with plans to reopen at LAX in late 2026.
* A refreshed Flagship(R) Dining menu debuts with chef-inspired dishes, regionally influenced flavors and seasonal ingredients.
* Chef Thomas ... Show Full Article FORT WORTH, Texas, Aug. 25 -- American Airlines posted the following news: * * * American Airlines celebrates expanded access to Flagship Dining with exclusive offering from KHK Wines and K+M Extravirgin Chocolate pairing curated by Chef Thomas Keller * American Airlines expands Flagship(R) Dining access, bringing its premium sit-down dining experience to more eligible customers at DFW and MIA beginning Sept. 15, with plans to reopen at LAX in late 2026. * A refreshed Flagship(R) Dining menu debuts with chef-inspired dishes, regionally influenced flavors and seasonal ingredients. * Chef ThomasKeller, co-founder of K+M Extravirgin Chocolate and a founding ambassador in Keller Hall Keller (KHK) Wines, brings an exclusive wine and chocolate pairing to Flagship(R) Dining guests and visitors to The Chelsea Lounge(R) club. As part of the collaboration, KHK cabernet sauvignon will also be available in all Flagship(R) lounges, adding another elevated touch to American's premium lounge experience.
-
Flagship(R) Dining, the premium American Airlines sit-down dining experience available in Flagship(R) lounges at Dallas Fort Worth International Airport (DFW) and Miami International Airport (MIA), is expanding access eligibility to more customers. To further enhance the experience, American is introducing an exclusive wine and chocolate pairing featuring KHK Wines and K+M Extravirgin Chocolate for Flagship(R) Dining guests. Chef Thomas Keller, who co-founded K+M Extravirgin Chocolate with Italian olive oil producer Armando Manni and is a founding ambassador in KHK Wines, curated the pairing. The offering will also be available at The Chelsea Lounge(R) club at John F. Kennedy International Airport (JFK), adding another elevated touch to American's most premium lounge experiences.
Beginning Sept. 15, customers traveling in Flagship(R) Business Plus and Flagship(R) Business on qualifying long-haul international, transcontinental and Hawaii Flagship(R) routes can enjoy access to Flagship(R) Dining -- an opportunity previously offered to only those traveling in Flagship(R) First.
"At American, we're continually looking for ways to elevate the customer experience and create moments that make travel more memorable," said American's SVP of Customer Experience and Design Rhonda Crawford. "By expanding access to Flagship(R) Dining and introducing new menu enhancements, including an exclusive wine and chocolate pairing from KHK Wines and K+M Extravirgin Chocolate curated by Chef Thomas Keller, we're delivering an even more elevated hospitality experience that begins well before customers step on board."
The private Flagship(R) Dining experience will also reopen at Los Angeles International Airport (LAX) in late 2026. It's an ideal retreat, especially popular among international travelers on layovers or with longer flights ahead of them.
A reimagined Flagship Dining menu
Launching alongside the expanded access, American is unveiling a refreshed four-course Flagship(R) Dining menu curated by American's culinary team. Developed by American's chefs, the seasonal offerings blend regional flavors, thoughtfully sourced ingredients and refined culinary techniques to create an elevated dining experience inspired by some of the world's most celebrated restaurants. The refreshed menu will also feature regionally inspired entrees that showcase flavors unique to American's hubs, including, but not limited to:
"What KHK imagined with their terroir, lifetime experiences and feet-firmly-rooted-in-reality philosophy is, for me, a rare opportunity to make an extremely high-quality, classic Napa Cab that is absolutely within reach. I'm thrilled to be creating it with them," said winemaker Thomas Rivers Brown.
Updated Flagship Dining access
Under the updated policy, access is available to customers traveling in Flagship(R) Business on qualifying long-haul international, transcontinental and Hawaii Flagship(R) routes.
These updates align Flagship(R) Dining access more closely with the premium travel experience while ensuring customers traveling on eligible Flagship itineraries can enjoy the benefit as part of their journey.
Flagship(R) Dining is available on a space-available basis. Customers interested in dining should check in with the host team inside the Flagship(R) lounge upon arrival. If a table is immediately available, customers will be seated at that time. If all tables are occupied, customers may be added to an electronic waitlist and will be notified when their table is ready. Wait times may vary based on lounge demand and flight schedules.
* * *
About American Airlines Group (NASDAQ: AAL)
American Airlines is a premium global airline connecting more of the U.S. to the world. With roots tracing back to an air mail carrier in the Midwestern United States in 1926, American now operates more than 6,000 daily flights to more than 350 destinations in more than 60 countries and serves more than 200 million customers annually. Powered by a proud and talented team of 130,000 aviation professionals, American's team lives out the airline's purpose of caring for people on life's journey every day.
The world's largest airline proudly celebrates its centennial year in 2026, reaching a milestone that reflects a century of innovation and the Forever Forward spirit that changed the industry and the world. American introduced the first scheduled air cargo service, the first airport lounge and the first airline loyalty program and continues to reinvent the customer experience today. The airline is also a founding member of the oneworld alliance, whose members serve more than 900 destinations around the globe.
Get the latest about American at news.aa.com and @AmericanAir.
* * *
Original text here: https://news.aa.com/news/news-details/2026/American-Airlines-celebrates-expanded-access-to-Flagship-Dining-with-exclusive-offering-from-KHK-Wines-and-KM-Extravirgin-Chocolate-pairing-MKG-LNGE-08/default.aspx
[Category: BizAerospace]
* * *
American Airlines celebrates expanded access to Flagship Dining with exclusive offering from KHK Wines and K+M Extravirgin Chocolate pairing curated by Chef Thomas Keller
* American Airlines expands Flagship(R) Dining access, bringing its premium sit-down dining experience to more eligible customers at DFW and MIA beginning Sept. 15, with plans to reopen at LAX in late 2026.
* A refreshed Flagship(R) Dining menu debuts with chef-inspired dishes, regionally influenced flavors and seasonal ingredients.
* Chef Thomas ... Show Full Article FORT WORTH, Texas, Aug. 25 -- American Airlines posted the following news: * * * American Airlines celebrates expanded access to Flagship Dining with exclusive offering from KHK Wines and K+M Extravirgin Chocolate pairing curated by Chef Thomas Keller * American Airlines expands Flagship(R) Dining access, bringing its premium sit-down dining experience to more eligible customers at DFW and MIA beginning Sept. 15, with plans to reopen at LAX in late 2026. * A refreshed Flagship(R) Dining menu debuts with chef-inspired dishes, regionally influenced flavors and seasonal ingredients. * Chef ThomasKeller, co-founder of K+M Extravirgin Chocolate and a founding ambassador in Keller Hall Keller (KHK) Wines, brings an exclusive wine and chocolate pairing to Flagship(R) Dining guests and visitors to The Chelsea Lounge(R) club. As part of the collaboration, KHK cabernet sauvignon will also be available in all Flagship(R) lounges, adding another elevated touch to American's premium lounge experience.
-
Flagship(R) Dining, the premium American Airlines sit-down dining experience available in Flagship(R) lounges at Dallas Fort Worth International Airport (DFW) and Miami International Airport (MIA), is expanding access eligibility to more customers. To further enhance the experience, American is introducing an exclusive wine and chocolate pairing featuring KHK Wines and K+M Extravirgin Chocolate for Flagship(R) Dining guests. Chef Thomas Keller, who co-founded K+M Extravirgin Chocolate with Italian olive oil producer Armando Manni and is a founding ambassador in KHK Wines, curated the pairing. The offering will also be available at The Chelsea Lounge(R) club at John F. Kennedy International Airport (JFK), adding another elevated touch to American's most premium lounge experiences.
Beginning Sept. 15, customers traveling in Flagship(R) Business Plus and Flagship(R) Business on qualifying long-haul international, transcontinental and Hawaii Flagship(R) routes can enjoy access to Flagship(R) Dining -- an opportunity previously offered to only those traveling in Flagship(R) First.
"At American, we're continually looking for ways to elevate the customer experience and create moments that make travel more memorable," said American's SVP of Customer Experience and Design Rhonda Crawford. "By expanding access to Flagship(R) Dining and introducing new menu enhancements, including an exclusive wine and chocolate pairing from KHK Wines and K+M Extravirgin Chocolate curated by Chef Thomas Keller, we're delivering an even more elevated hospitality experience that begins well before customers step on board."
The private Flagship(R) Dining experience will also reopen at Los Angeles International Airport (LAX) in late 2026. It's an ideal retreat, especially popular among international travelers on layovers or with longer flights ahead of them.
A reimagined Flagship Dining menu
Launching alongside the expanded access, American is unveiling a refreshed four-course Flagship(R) Dining menu curated by American's culinary team. Developed by American's chefs, the seasonal offerings blend regional flavors, thoughtfully sourced ingredients and refined culinary techniques to create an elevated dining experience inspired by some of the world's most celebrated restaurants. The refreshed menu will also feature regionally inspired entrees that showcase flavors unique to American's hubs, including, but not limited to:
"What KHK imagined with their terroir, lifetime experiences and feet-firmly-rooted-in-reality philosophy is, for me, a rare opportunity to make an extremely high-quality, classic Napa Cab that is absolutely within reach. I'm thrilled to be creating it with them," said winemaker Thomas Rivers Brown.
Updated Flagship Dining access
Under the updated policy, access is available to customers traveling in Flagship(R) Business on qualifying long-haul international, transcontinental and Hawaii Flagship(R) routes.
These updates align Flagship(R) Dining access more closely with the premium travel experience while ensuring customers traveling on eligible Flagship itineraries can enjoy the benefit as part of their journey.
Flagship(R) Dining is available on a space-available basis. Customers interested in dining should check in with the host team inside the Flagship(R) lounge upon arrival. If a table is immediately available, customers will be seated at that time. If all tables are occupied, customers may be added to an electronic waitlist and will be notified when their table is ready. Wait times may vary based on lounge demand and flight schedules.
* * *
About American Airlines Group (NASDAQ: AAL)
American Airlines is a premium global airline connecting more of the U.S. to the world. With roots tracing back to an air mail carrier in the Midwestern United States in 1926, American now operates more than 6,000 daily flights to more than 350 destinations in more than 60 countries and serves more than 200 million customers annually. Powered by a proud and talented team of 130,000 aviation professionals, American's team lives out the airline's purpose of caring for people on life's journey every day.
The world's largest airline proudly celebrates its centennial year in 2026, reaching a milestone that reflects a century of innovation and the Forever Forward spirit that changed the industry and the world. American introduced the first scheduled air cargo service, the first airport lounge and the first airline loyalty program and continues to reinvent the customer experience today. The airline is also a founding member of the oneworld alliance, whose members serve more than 900 destinations around the globe.
Get the latest about American at news.aa.com and @AmericanAir.
* * *
Original text here: https://news.aa.com/news/news-details/2026/American-Airlines-celebrates-expanded-access-to-Flagship-Dining-with-exclusive-offering-from-KHK-Wines-and-KM-Extravirgin-Chocolate-pairing-MKG-LNGE-08/default.aspx
[Category: BizAerospace]
Mayer Brown Appoints Erica Murphy as Chief People and Talent Officer
CHICAGO, Illinois, Aug. 25 [Category: BizLaw/Legal] -- Mayer Brown, a law firm, issued the following news on Aug. 24, 2026:
* * *
Mayer Brown appoints Erica Murphy as chief people and talent officer
NEW YORK - Mayer Brown announced today that Erica Murphy has joined the firm as chief people and talent officer. In her new role, Erica will lead the firm's global people strategy, including talent management, professional development, workforce planning, employee engagement, recruitment, and total rewards.
Erica joins Mayer Brown from Ropes & Gray, where she served as chief human resources officer ... Show Full Article CHICAGO, Illinois, Aug. 25 [Category: BizLaw/Legal] -- Mayer Brown, a law firm, issued the following news on Aug. 24, 2026: * * * Mayer Brown appoints Erica Murphy as chief people and talent officer NEW YORK - Mayer Brown announced today that Erica Murphy has joined the firm as chief people and talent officer. In her new role, Erica will lead the firm's global people strategy, including talent management, professional development, workforce planning, employee engagement, recruitment, and total rewards. Erica joins Mayer Brown from Ropes & Gray, where she served as chief human resources officerand a member of the firm's senior leadership team. She brings more than 25 years of experience in human resources, talent strategy, organizational development, and law firm management, including an early career as a labor and employment attorney.
"Erica is a highly respected and talented leader whose experience, strategic mindset, and collaborative approach will be invaluable as we continue to invest in our people and strengthen our culture across the firm," said Jeremy Clay, managing partner of Mayer Brown. "Her leadership will help ensure we remain well-positioned to attract, develop, and retain exceptional talent around the world."
Erica said she was drawn to Mayer Brown's collaborative culture, engaged leadership, and forward-thinking commitment to a world-class talent function.
"Mayer Brown is a firm with a strong culture, ambitious vision, and a clear commitment to its people," said Erica. "I am excited to join the firm at a time of significant change in the legal profession and to help build talent strategies that support our people, clients, and long-term success."
* * *
Original text here: https://www.mayerbrown.com/en/news/2026/08/mayer-brown-appoints-erica-murphy-as-chief-people-and-talent-officer
* * *
Mayer Brown appoints Erica Murphy as chief people and talent officer
NEW YORK - Mayer Brown announced today that Erica Murphy has joined the firm as chief people and talent officer. In her new role, Erica will lead the firm's global people strategy, including talent management, professional development, workforce planning, employee engagement, recruitment, and total rewards.
Erica joins Mayer Brown from Ropes & Gray, where she served as chief human resources officer ... Show Full Article CHICAGO, Illinois, Aug. 25 [Category: BizLaw/Legal] -- Mayer Brown, a law firm, issued the following news on Aug. 24, 2026: * * * Mayer Brown appoints Erica Murphy as chief people and talent officer NEW YORK - Mayer Brown announced today that Erica Murphy has joined the firm as chief people and talent officer. In her new role, Erica will lead the firm's global people strategy, including talent management, professional development, workforce planning, employee engagement, recruitment, and total rewards. Erica joins Mayer Brown from Ropes & Gray, where she served as chief human resources officerand a member of the firm's senior leadership team. She brings more than 25 years of experience in human resources, talent strategy, organizational development, and law firm management, including an early career as a labor and employment attorney.
"Erica is a highly respected and talented leader whose experience, strategic mindset, and collaborative approach will be invaluable as we continue to invest in our people and strengthen our culture across the firm," said Jeremy Clay, managing partner of Mayer Brown. "Her leadership will help ensure we remain well-positioned to attract, develop, and retain exceptional talent around the world."
Erica said she was drawn to Mayer Brown's collaborative culture, engaged leadership, and forward-thinking commitment to a world-class talent function.
"Mayer Brown is a firm with a strong culture, ambitious vision, and a clear commitment to its people," said Erica. "I am excited to join the firm at a time of significant change in the legal profession and to help build talent strategies that support our people, clients, and long-term success."
* * *
Original text here: https://www.mayerbrown.com/en/news/2026/08/mayer-brown-appoints-erica-murphy-as-chief-people-and-talent-officer